Animal Intestinal Health Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Livestock (Aquaculture, Poultry, Ruminant, Swine, Others), By Additive (Probiotics, Prebiotics, Immunostimulants, Phytogenics), By Form (Dry, Liquid), By Source (Microbial, Plant Based), By Region and Competition, 2019-2029F
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationAnimal Intestinal Health Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Livestock (Aquaculture, Poultry, Ruminant, Swine, Others), By Additive (Probiotics, Prebiotics, Immunostimulants, Phytogenics), By Form (Dry, Liquid), By Source (Microbial, Plant Based), By Region and Competition, 2019-2029F
Forecast Period | 2025-2029 |
Market Size (2023) | USD 3.54 Billion |
CAGR (2024-2029) | 7.78% |
Fastest Growing Segment | Poultry |
Largest Market | North America |
Market Size (2029) | USD 5.50 Billion |
Download Sample Ask for Discount Request Customization
Market Overview
Global Animal Intestinal Health Market was valued at USD 3.54 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 7.78% through 2029.
The Animal Intestinal Health Market refers to the industry focused on products and services that maintain or improve the gut health of various animal species. This includes livestock and pets, and encompasses everything from feed additives (like prebiotics, probiotics, and phytogenics), to diagnostic services, and treatments for conditions such as intestinal infections or disorders. The market's growth is driven by increasing awareness of the importance of animal health, the demand for quality animal-derived products, and advancements in animal healthcare research and product development.
Key Market Drivers
Increasing Prevalence of Animal Diseases
The global demand for animal intestinal health solutions is witnessing a significant surge, driven by the increasing prevalence of animal diseases within the livestock and poultry industries. As the frequency and impact of diseases affecting the gastrointestinal tract of animals continue to rise, there is a growing recognition among livestock producers and veterinarians of the critical role that intestinal health plays in overall animal well-being and performance. The heightened prevalence of diseases such as enteric infections and digestive disorders necessitates a proactive approach to maintaining and improving animal intestinal health. This has led to an increased demand for specialized products and solutions designed to support digestive function, enhance nutrient absorption, and strengthen the immune system of livestock and poultry.
Advances in Veterinary Medicine & Animal Healthcare
The global demand for animal intestinal health solutions is experiencing a notable upswing, propelled by continuous advances in veterinary medicine and animal healthcare. As the field of veterinary science evolves with cutting-edge technologies, there is a growing recognition of the interconnectedness between overall animal health and the well-being of the gastrointestinal system. Veterinarians, livestock producers, and pet owners are increasingly aware of the pivotal role that intestinal health plays in maintaining the overall health and performance of animals. Advancements in veterinary medicine have led to a deeper understanding of the intricate interactions within the animal gut microbiome and its impact on immune function, nutrient absorption, and disease resistance. This enhanced knowledge has spurred the development of innovative solutions such as probiotics, prebiotics, and specialized feed additives designed to support and optimize animal intestinal health.
The demand for these advanced intestinal health products is escalating globally as livestock producers, pet owners, and animal caretakers seek proactive measures to prevent diseases and enhance the well-being of their animals. This trend is further fueled by a growing consumer emphasis on the humane treatment and optimal health of animals in various sectors, from livestock farming to pet care. The intersection of veterinary medicine breakthroughs and the increasing demand for animal intestinal health solutions reflects a paradigm shift toward preventive and holistic approaches in animal healthcare. As the industry continues to embrace these advances, the global market for intestinal health products is poised for sustained growth, aligning with the broader goals of promoting animal welfare and ensuring the health and productivity of diverse animal populations.
Download Sample Ask for Discount Request Customization
Growing Adoption of Prebiotics & Probiotics
The global demand for animal intestinal health solutions is experiencing a significant upsurge, driven by the growing adoption of prebiotics and probiotics in animal nutrition. As the understanding of the crucial role played by the gut microbiome in animal health deepens, there is a notable shift towards incorporating these beneficial microorganisms into animal diets. Probiotics, which are live beneficial bacteria, and prebiotics, which are non-digestible fibers that support the growth of beneficial bacteria, are gaining widespread acceptance as integral components in promoting and maintaining intestinal health.
Livestock producers, pet owners, and animal nutritionists are increasingly recognizing the potential of prebiotics and probiotics to enhance digestion, nutrient absorption, and overall immune function in animals. The demand for these microbial-based solutions is escalating globally as a proactive approach to prevent gastrointestinal issues and improve the overall well-being of diverse animal species. The positive impact of prebiotics and probiotics on animal intestinal health aligns with the broader industry trend towards sustainable and science-backed practices. These microbial supplements not only contribute to better gut health but also support efficient and responsible animal farming practices. As consumer awareness of the connection between animal nutrition and health grows, the demand for products that prioritize intestinal well-being is set to remain robust, marking a transformative era in global animal husbandry practices where the adoption of prebiotics and probiotics becomes integral to achieving optimal intestinal health across various animal sectors.
Increased Focus on Preventive Healthcare for Animals
The global demand for animal intestinal health solutions is witnessing a substantial upswing, driven by an increased focus on preventive healthcare for animals across diverse sectors of the industry. With a growing awareness of the importance of proactively managing animal health, there is a heightened recognition that intestinal well-being plays a pivotal role in overall health and disease prevention. Livestock producers, pet owners, and animal caretakers are shifting towards a preventive approach, seeking solutions that promote intestinal health to preclude the onset of digestive disorders and related illnesses. This shift is reflected in the escalating demand for products such as prebiotics, probiotics, and other specialized feed additives designed to maintain a healthy gut microbiome.
The emphasis on preventive healthcare for animals is not only driven by a desire to enhance animal welfare but also aligns with the broader industry goals of sustainable and responsible farming practices. By prioritizing intestinal health, stakeholders aim to reduce the reliance on therapeutic interventions and antibiotics, contributing to more holistic and environmentally friendly approaches to animal care. As the global focus on preventive healthcare gains momentum, the demand for effective solutions that support animal intestinal health is set to grow. This trend underscores a transformative shift in the industry's approach, where proactive measures to enhance intestinal well-being are becoming integral to achieving sustainable and optimal health outcomes for livestock, pets, and other animals worldwide.
Key Market Challenges
Lack of Research & Development (R&D)
The global demand for animal intestinal health solutions is facing a decline, primarily attributed to a lack of Research and Development (R&D) in the field. The absence of significant advancements and innovation in understanding and addressing intestinal health challenges in animals has led to a stagnant product landscape. This lack of R&D hampers the development of novel and effective solutions, limiting the options found at to livestock producers, veterinarians, and pet owners seeking advanced products to support intestinal well-being. Without substantial investment in research, the industry struggles to introduce cutting-edge technologies and scientifically backed formulations that could offer breakthroughs in promoting animal intestinal health. Stakeholders are hesitant to invest in existing products when the potential for revolutionary solutions remains untapped due to insufficient R&D efforts.
The consequences of this dearth in research and development are evident across various sectors, from livestock farming to companion animal care. The limited availability of innovative products hinders the industry's ability to address emerging challenges and evolving needs in animal intestinal health effectively. To revitalize the demand for animal intestinal health solutions globally, there is a crucial need for increased investments in R&D. The industry must prioritize research initiatives that explore new technologies, formulations, and approaches, fostering a culture of innovation that can elevate the standard of care for animal intestinal health on a global scale.
Download Sample Ask for Discount Request Customization
Lack of Veterinary Services
The global demand for animal intestinal health solutions is experiencing a downturn, largely due to a lack of access to veterinary services. In many regions, especially in developing economies, the scarcity of qualified veterinarians and limited veterinary infrastructure constrains the ability of livestock producers and pet owners to address intestinal health issues effectively. The absence of readily found at expertise and guidance in managing and preventing gastrointestinal problems in animals contributes to a decreased demand for specialized products aimed at intestinal health.
The inadequate provision of veterinary services impacts both the livestock industry and the companion animal sector. Livestock producers may struggle to implement preventive measures and treatment plans for their animals, hindering overall herd health and productivity. Pet owners, facing challenges in accessing veterinary care, may resort to conventional and less targeted approaches, affecting the demand for advanced intestinal health solutions.
The global market response underscores the interconnectedness between veterinary services and the demand for products promoting animal intestinal health. Efforts to increase the availability of veterinary services, particularly in underserved regions, are essential to reinvigorate the demand for these solutions. A comprehensive approach that includes training, infrastructure development, and awareness campaigns can bridge the gap, ensuring that animals worldwide receive the necessary care and interventions to maintain optimal intestinal health.
Key Market Trends
Introduction of Innovative Animal Healthcare Products
The global demand for animal intestinal health solutions is experiencing a significant boost, propelled by the introduction of innovative animal healthcare products that specifically target and enhance digestive well-being. The continuous development and introduction of novel solutions, including advanced probiotics, prebiotics, and specialized feed additives, are reshaping the landscape of animal intestinal health globally. These innovative products leverage cutting-edge research and technologies to address specific challenges related to gastrointestinal health in diverse animal species. Livestock producers, pet owners, and veterinarians are increasingly embracing these novel offerings as a means to optimize animal health, prevent digestive disorders, and improve overall performance. The market response reflects a growing recognition that innovation in animal healthcare can provide effective and sustainable solutions to support intestinal health.
The demand for innovative animal healthcare products also aligns with broader industry trends emphasizing sustainable and science-driven practices. The introduction of these products not only addresses existing challenges in animal health but also contributes to reducing the need for therapeutic interventions, such as antibiotics, fostering a more holistic and responsible approach to animal care. As consumer awareness of the connection between animal nutrition and health continues to rise, the global market for animal intestinal health is poised for continued growth. Stakeholders across the industry are witnessing an increased willingness to invest in and adopt these innovative solutions, marking a transformative era where advanced animal healthcare products play a crucial role in achieving optimal intestinal health outcomes for livestock, companion animals, and other species worldwide.
Growing Trend of Adopting Companion Animals
The global demand for animal intestinal health solutions is on the rise, propelled by the growing trend of adopting companion animals worldwide. As more individuals and families welcome pets into their homes, there is a heightened awareness of the importance of maintaining the digestive well-being of these cherished animal companions. The increasing recognition that a healthy gut is fundamental to overall pet health has spurred a surge in demand for specialized products, including probiotics and dietary supplements, aimed at supporting optimal intestinal function.
Pet owners are becoming more proactive in seeking preventive measures to ensure the well-being of their furry friends, and this includes a focus on maintaining a balanced and healthy gut microbiome. The demand for animal intestinal health products is particularly pronounced in the companion animal sector, where pet owners are investing in innovative solutions designed to address specific digestive challenges and promote a resilient immune system.
The global market response reflects a paradigm shift in pet care, where the emphasis is not only on treating illnesses but also on preventive healthcare to enhance the overall quality of life for companion animals. Stakeholders in the animal health industry are witnessing a growing willingness among pet owners to prioritize intestinal health, contributing to the broader trend of responsible pet ownership. As the adoption of companion animals continues to rise, the demand for effective and science-backed intestinal health solutions is poised to remain a focal point in the evolving landscape of the global pet care market.
Segmental Insights
Livestock Insights
Based on Livestock, Poultry have emerged as the fastest growing segment in the Global Animal Intestinal Health Market in 2023.
Additive Insights
Based on Additive, Probiotics have emerged as the dominating segment in the Global Animal Intestinal Health Market in 2023.
Regional Insights
Based on Region, North America have emerged as the dominating region in the Global Animal Intestinal Health Market in 2023. the region boasts advanced animal health infrastructure that supports the well-being of livestock. This infrastructure includes state-of-the-art veterinary clinics, research facilities, and technology-driven solutions. There is an increasing demand for livestock products in north America. With a growing population and changing dietary preferences, the demand for high-quality meat, dairy, and poultry products has been on the rise. This demand has led to a greater focus on maintaining the intestinal health of animals, ensuring their optimal growth and productivity.
Recent Development
- In October 2023, Evonik China Co., Ltd and Shandong Vland Biotech Co., Ltd entered into a joint venture to expand their global presence in gut health solutions for farm animals. This collaboration will leverage Vland's market access and regulatory expertise in China, along with its rapid innovation capabilities. Additionally, the joint venture will capitalize on Evonik’s global sales network, R&D, and regulatory strengths. The new venture is projected to generate sales in the low double-digit million euro range. Earlier this year, Evonik announced its plans to enhance its specialty nutrition business with system solutions and specialties for poultry, swine, and ruminants. The partnership with Vland on gut health solutions is a key component of Evonik’s strategy to provide comprehensive system solutions for its customers in the animal feed industry.
Key Market Players
- AB Agri Limited
- Cargill, Incorporated
- Calpis Co., Ltd.
- Chr. Hansen A/S
- Dr. Eckel Animal Nutrition GmbH & Co. KG
- Evonik Industries AG
- Kemin Industries, Inc.
- Koninklijke DSM N.V.
- Lallemand Inc.
By Livestock |
By Additive |
By Form |
By Source |
By Region |
|
||
|
|
|
|
|
|
||
Table of Content
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 38)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
FIGURE 1 MARKET SEGMENTATION
1.3.1 REGIONS COVERED
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
TABLE 1 USD EXCHANGE RATES CONSIDERED, 2019–2021
1.6 UNIT CONSIDERED
1.7 STAKEHOLDERS
1.8 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 43)
2.1 RESEARCH DATA
FIGURE 2 ANIMAL INTESTINAL HEALTH MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primary interviews
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY VALUE CHAIN, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 4 ANIMAL INTESTINAL HEALTH MARKET SIZE ESTIMATION: SUPPLY SIDE (1/2)
FIGURE 5 ANIMAL INTESTINAL HEALTH (AIH) MARKET SIZE ESTIMATION: SUPPLY SIDE (2/2)
FIGURE 6 ANIMAL INTESTINAL HEALTH MARKET SIZE ESTIMATION: DEMAND SIDE
2.2.1 BOTTOM-UP APPROACH
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS
2.4.1 ASSUMPTIONS
2.4.2 LIMITATIONS
3 EXECUTIVE SUMMARY (Page No. - 53)
FIGURE 10 PROBIOTICS SEGMENT EXPECTED TO ACCOUNT FOR LARGEST MARKET SIZE BY 2027
FIGURE 11 POULTRY SEGMENT EXPECTED TO ACCOUNT FOR LARGEST MARKET SIZE BY 2027
FIGURE 12 DRY FORM SEGMENT EXPECTED TO ACCOUNT FOR A LARGER MARKET SHARE BY 2022
FIGURE 13 MICROBIAL SEGMENT EXPECTED TO ACCOUNT FOR LARGER MARKET SIZE BY 2027
FIGURE 14 ASIA PACIFIC EXPECTED TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022
4 PREMIUM INSIGHTS (Page No. - 57)
4.1 OPPORTUNITIES IN ANIMAL INTESTINAL HEALTH MARKET
FIGURE 15 INCREASE IN DEMAND FOR FEED AND FEED ADDITIVES DRIVING GROWTH OF ANIMAL INTESTINAL HEALTH MARKET
4.2 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE
FIGURE 16 PROBIOTICS SEGMENT EXPECTED TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022
4.3 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK AND KEY COUNTRIES
FIGURE 17 CHINA AND POULTRY SEGMENT EXPECTED TO ACCOUNT FOR SIGNIFICANT MARKET SHARE IN ASIA PACIFIC MARKET IN 2022
4.4 ANIMAL INTESTINAL HEALTH MARKET, BY FORM AND REGION
FIGURE 18 DRY SEGMENT EXPECTED TO ACCOUNT FOR LARGER MARKET SHARE IN 2022
4.5 ANIMAL INTESTINAL HEALTH MARKET, BY MAJOR REGIONAL SUBMARKETS
FIGURE 19 INCREASING CONSUMPTION OF MEAT IS EXPECTED TO DRIVE THE GROWTH IN ASIA PACIFIC REGION
5 MARKET OVERVIEW (Page No. - 60)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 20 ANIMAL INTESTINAL HEALTH MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increased production of compound feed
FIGURE 21 GLOBAL COMPOUND FEED PRODUCTION, 2012–2021 (MILLION METRIC TONS)
FIGURE 22 COMPOUND FEED PRODUCTION, BY TOP 7 COUNTRIES, 2016–2020 (MILLION METRIC TONS)
5.2.1.2 Rising demand for animal protein
TABLE 2 PER CAPITA CONSUMPTION OF LIVESTOCK PRODUCTS, BY REGION
5.2.1.3 Intestinal disorders among livestock
5.2.2 RESTRAINTS
5.2.2.1 Stringent regulations for use of feed additives
5.2.3 OPPORTUNITIES
5.2.3.1 Innovations and technological advancements in feed industry
5.2.3.2 Increased awareness about feed and food safety
5.2.4 CHALLENGES
5.2.4.1 High cost of feed additives
5.2.4.1.1 R&D costs associated with development of probiotics
5.2.4.1.2 High cost of active ingredients used in development of phytogenic feed additives
6 INDUSTRY TRENDS (Page No. - 67)
6.1 INTRODUCTION
6.2 TRENDS IMPACTING CUSTOMERS’ BUSINESS
FIGURE 23 TRENDS IMPACTING ANIMAL INTESTINAL HEALTH MARKET
6.3 VALUE CHAIN
FIGURE 24 VALUE CHAIN ANALYSIS
6.4 TRADE ANALYSIS
FIGURE 25 EXPORT OF LIVESTOCK SPECIES, 2016–2021 (USD MILLION)
6.5 TECHNOLOGY ANALYSIS
6.6 PATENT ANALYSIS
TABLE 3 KEY PATENTS PERTAINING TO ANIMAL INTESTINAL HEALTH, 2019–2022
6.7 ECOSYSTEM MAP
6.7.1 ANIMAL INTESTINAL HEALTH MARKET: ECOSYSTEM MAP
FIGURE 26 FEED AND ANIMAL NUTRITION: ECOSYSTEM MAP
6.8 PORTER’S FIVE FORCES ANALYSIS
TABLE 4 PORTER’S FIVE FORCES ANALYSIS
6.8.1 THREAT OF NEW ENTRANTS
6.8.2 THREAT OF SUBSTITUTES
6.8.3 BARGAINING POWER OF SUPPLIERS
6.8.4 BARGAINING POWER OF BUYERS
6.8.5 INTENSITY OF COMPETITIVE RIVALRY
6.9 CASE STUDIES
6.9.1 REGULATIONS ON ANTIBIOTICS LEADING TO A SHIFT TOWARD PROBIOTICS
6.10 PRICING ANALYSIS
6.10.1 ANIMAL INTESTINAL HEALTH MARKET: AVERAGE SELLING PRICE TREND ANALYSIS
TABLE 5 AVERAGE SELLING PRICE, BY ADDITIVE, 2019–2027 (USD/KG)
6.11 REGULATORY FRAMEWORK
6.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.11.2 CODEX ALIMENTARIUS COMMISSION (CAC)
6.11.2.1 North America
6.11.2.2 Europe
6.11.2.3 Asia Pacific
6.12 KEY STAKEHOLDERS AND BUYING CRITERIA
6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING ANIMAL INTESTINAL HEALTH PRODUCTS
TABLE 6 INFLUENCE OF STAKEHOLDERS ON TOP THREE PRODUCT TYPES
6.12.2 BUYING CRITERIA
FIGURE 28 KEY BUYING CRITERIA FOR ADDITIVES
TABLE 7 KEY BUYING CRITERIA FOR ADDITIVES
6.13 KEY CONFERENCES AND EVENTS, 2022–2023
TABLE 8 ANIMAL INTESTINAL HEALTH MARKET: DETAILED LIST OF CONFERENCES & EVENTS, BY REGION, 2022–2023
7 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE (Page No. - 84)
7.1 INTRODUCTION
FIGURE 29 PROBIOTICS SEGMENT EXPECTED TO DOMINATE ANIMAL INTESTINAL HEALTH MARKET BY 2027
TABLE 9 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2021 (USD MILLION)
TABLE 10 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2022–2027 (USD MILLION)
TABLE 11 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2021 (KT)
TABLE 12 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2022–2027 (KT)
7.2 PROBIOTICS
7.2.1 PROBIOTIC MICROORGANISMS OFFER HEALTH BENEFITS
TABLE 13 PROBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2021 (USD MILLION)
TABLE 14 PROBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2022–2027 (USD MILLION)
TABLE 15 PROBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2021 (KT)
TABLE 16 PROBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2022–2027 (KT)
7.3 PREBIOTICS
7.3.1 PREBIOTICS INDUCE GROWTH OF BENEFICIAL GUT BACTERIA
7.3.1.1 Oligosaccharides
7.3.1.2 Inulin
7.3.1.3 Other additives
TABLE 17 PREBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2021 (USD MILLION)
TABLE 18 PREBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2022–2027 (USD MILLION)
TABLE 19 PREBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2021 (KT)
TABLE 20 PREBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2022–2027 (KT)
7.4 PHYTOGENICS
7.4.1 PHYTOGENIC FEED ADDITIVES OFFER MORE THAN FLAVORING PROPERTIES
7.4.1.1 Essential oils
7.4.1.2 Flavonoids
7.4.1.3 Saponins
7.4.1.4 Oleoresins
7.4.1.5 Other additives
TABLE 21 PHYTOGENICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2021 (USD MILLION)
TABLE 22 PHYTOGENICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2022–2027 (USD MILLION)
TABLE 23 PHYTOGENICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2021 (KT)
TABLE 24 PHYTOGENICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2022–2027 (KT)
7.5 IMMUNOSTIMULANTS
7.5.1 IMMUNOSTIMULANTS IMPROVE IMMUNITY AND REDUCE STRESS AND DISEASES IN AQUACULTURE
TABLE 25 IMMUNOSTIMULANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2021 (USD MILLION)
TABLE 26 IMMUNOSTIMULANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2022–2027 (USD MILLION)
TABLE 27 IMMUNOSTIMULANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2021 (KT)
TABLE 28 IMMUNOSTIMULANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2022–2027 (KT)
8 ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK (Page No. - 98)
8.1 INTRODUCTION
FIGURE 30 POULTRY SEGMENT EXPECTED TO DOMINATE ANIMAL INTESTINAL HEALTH MARKET DURING FORECAST PERIOD
TABLE 29 ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2021 (USD MILLION)
TABLE 30 ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2022–2027 (USD MILLION)
TABLE 31 ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2021 (KT)
TABLE 32 ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2022–2027 (KT)
8.2 POULTRY
8.2.1 FEED ADDITIVES ENHANCE POULTRY PERFORMANCE
TABLE 33 POULTRY: ANIMAL INTESTINAL HEALTH MARKET, BY TYPE, 2019–2021 (USD MILLION)
TABLE 34 POULTRY: ANIMAL INTESTINAL HEALTH MARKET, BY TYPE, 2022–2027 (USD MILLION)
TABLE 35 POULTRY: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2021 (USD MILLION)
TABLE 36 POULTRY: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2022–2027 (USD MILLION)
TABLE 37 POULTRY: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2021 (KT)
TABLE 38 POULTRY: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2022–2027 (KT)
8.2.1.1 Broilers
8.2.1.2 Layers
8.2.1.3 Turkey
8.2.1.4 Other poultry species
8.3 SWINE
8.3.1 RISE IN PORK TRADE AND CONCERNS OVER MEAT SAFETY
TABLE 39 PROBIOTIC MICROORGANISMS USED IN SWINE FEED
TABLE 40 SWINE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2021 (USD MILLION)
TABLE 41 SWINE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2022–2027 (USD MILLION)
TABLE 42 SWINE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2021 (KT)
TABLE 43 SWINE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2022–2027 (KT)
8.4 RUMINANTS
8.4.1 FEED ADDITIVES BOOST PRODUCTION EFFICIENCY IN RUMINANTS
TABLE 44 RUMINANTS: ANIMAL INTESTINAL HEALTH MARKET, BY TYPE, 2019–2021 (USD MILLION)
TABLE 45 RUMINANTS: ANIMAL INTESTINAL HEALTH MARKET, BY TYPE, 2022–2027 (USD MILLION)
TABLE 46 RUMINANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2021 (USD MILLION)
TABLE 47 RUMINANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2022–2027 (USD MILLION)
TABLE 48 RUMINANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2021 (KT)
TABLE 49 RUMINANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2022–2027 (KT)
8.4.1.1 Dairy cattle
8.4.1.2 Beef cattle
8.4.1.3 Calves
8.4.1.4 Other ruminant species
8.5 AQUACULTURE
8.5.1 FEED ADDITIVES IMPROVE FEED QUALITY AND ENHANCE AQUACULTURE PERFORMANCE
TABLE 50 AQUACULTURE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2021 (USD MILLION)
TABLE 51 AQUACULTURE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2022–2027 (USD MILLION)
TABLE 52 AQUACULTURE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2021 (KT)
TABLE 53 AQUACULTURE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2022–2027 (KT)
8.6 OTHER LIVESTOCK
8.6.1 PHYTOGENIC-BASED ANIMAL INTESTINAL PRODUCTS IMPROVE DIGESTIBILITY IN PETS
TABLE 54 OTHER LIVESTOCK: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2021 (USD MILLION)
TABLE 55 OTHER LIVESTOCK: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2022–2027 (USD MILLION)
TABLE 56 OTHER LIVESTOCK: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2021 (KT)
TABLE 57 OTHER LIVESTOCK: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2022–2027 (KT)
9 ANIMAL INTESTINAL HEALTH MARKET, BY FORM (Page No. - 114)
9.1 INTRODUCTION
FIGURE 31 DRY SEGMENT EXPECTED TO DOMINATE ANIMAL INTESTINAL HEALTH MARKET DURING FORECAST PERIOD
TABLE 58 ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2021 (USD MILLION)
TABLE 59 ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2022–2027 (USD MILLION)
TABLE 60 ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2021 (KT)
TABLE 61 ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2022–2027 (KT)
9.2 DRY
9.2.1 EASE OF STORAGE AND TRANSPORTATION
TABLE 62 DRY FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2021(USD MILLION)
TABLE 63 DRY FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2022–2027 (USD MILLION)
TABLE 64 DRY FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2021(KT)
TABLE 65 DRY FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2022–2027 (KT)
9.3 LIQUID
9.3.1 LIQUID SUPPLEMENTS PROVIDE UNIFORM TEXTURE TO FINAL PRODUCTS
TABLE 66 LIQUID FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2021 (USD MILLION)
TABLE 67 LIQUID FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2022–2027 (USD MILLION)
TABLE 68 LIQUID FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2021 (KT)
TABLE 69 LIQUID FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2022–2027 (KT)
10 ANIMAL INTESTINAL HEALTH MARKET, BY FUNCTION (Page No. - 122)
10.1 METABOLISM
10.1.1 ADDITIVES IMPROVE SURVIVAL AND IMPLANTATION OF LIVE MICROBIAL DIETARY SUPPLEMENTS IN GI TRACT
10.2 WEIGHT GAIN
10.2.1 FEED ADDITIVES IMPROVE PRODUCTION AND PERFORMANCE OF RUMINANTS
10.3 NUTRIENT DIGESTION
10.3.1 FEED ADDITIVES IMPROVE DIGESTIBILITY OF NUTRIENTS
10.4 DISEASE PREVENTION
10.4.1 USE OF FEED ADDITIVES PREVENTS DISEASES IN ANIMALS AND IMPROVES HEALTH
10.5 BONE AND JOINT HEALTH
10.5.1 PREBIOTICS BETTER CALCIUM METABOLISM AND BONE HEALTH
11 ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE (Page No. - 125)
11.1 INTRODUCTION
FIGURE 32 MICROBIAL SEGMENT EXPECTED TO DOMINATE ANIMAL INTESTINAL HEALTH MARKET DURING FORECAST PERIOD
TABLE 70 ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2021 (USD MILLION)
TABLE 71 ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2022–2027 (USD MILLION)
TABLE 72 ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2021 (KT)
TABLE 73 ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2022–2027 (KT)
11.2 MICROBIAL
11.2.1 PROBIOTICS PREPARED USING BACILLUS SUBTILIS AND STREPTOCOCCI IMPROVE EFFICIENCY IN POULTRY AND SWINE
TABLE 74 MICROBIAL: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2021 (USD MILLION)
TABLE 75 MICROBIAL: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2022–2027 (USD MILLION)
TABLE 76 MICROBIAL: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2021 (KT)
TABLE 77 MICROBIAL: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2022–2027 (KT)
11.3 PLANT-BASED
11.3.1 PLANT-BASED SUBSTANCES IMPROVE NUTRIENT DIGESTIBILITY IN ANIMALS
TABLE 78 PLANT-BASED: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2021 (USD MILLION)
TABLE 79 PLANT-BASED: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2022–2027 (USD MILLION)
TABLE 80 PLANT-BASED: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2021 (KT)
TABLE 81 PLANT-BASED: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2022–2027 (KT)
12 ANIMAL INTESTINAL HEALTH MARKET, BY REGION (Page No. - 133)
12.1 INTRODUCTION
FIGURE 33 INDIA EXPECTED TO WITNESS HIGH GROWTH IN ANIMAL INTESTINAL HEALTH MARKET BETWEEN 2022 AND 2027
TABLE 82 ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2021 (USD MILLION)
TABLE 83 ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2022–2027 (USD MILLION)
TABLE 84 ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2021 (KT)
TABLE 85 ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2022–2027(KT)
12.2 NORTH AMERICA
FIGURE 34 NORTH AMERICA: MARKET SNAPSHOT
TABLE 86 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2021 (USD MILLION)
TABLE 87 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2022–2027 (USD MILLION)
TABLE 88 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2021 (USD MILLION)
TABLE 89 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2022–2027 (USD MILLION)
TABLE 90 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2021 (KT)
TABLE 91 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2022–2027 (KT)
TABLE 92 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2021 (USD MILLION)
TABLE 93 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2022–2027 (USD MILLION)
TABLE 94 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2021 (KT)
TABLE 95 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2022–2027 (KT)
TABLE 96 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2021 (USD MILLION)
TABLE 97 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2022–2027 (USD MILLION)
TABLE 98 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2021 (KT)
TABLE 99 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2022–2027 (KT)
TABLE 100 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2021 (USD MILLION)
TABLE 101 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2022–2027 (USD MILLION)
TABLE 102 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2021 (KT)
TABLE 103 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2022–2027 (KT)
12.2.1 US
12.2.1.1 Rise in consumption of poultry products
TABLE 104 US: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2021 (USD MILLION)
TABLE 105 US: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2022–2027 (USD MILLION)
12.2.2 CANADA
12.2.2.1 Food safety concerns and government regulations
TABLE 106 CANADA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2021 (USD MILLION)
TABLE 107 CANADA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2022–2027 (USD MILLION)
12.2.3 MEXICO
12.2.3.1 Rise in import of high-quality meat products
TABLE 108 MEXICO: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2021 (USD MILLION)
TABLE 109 MEXICO: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2022–2027 (USD MILLION)
12.3 EUROPE
TABLE 110 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2021 (USD MILLION)
TABLE 111 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2022–2027 (USD MILLION)
TABLE 112 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2021 (USD MILLION)
TABLE 113 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2022–2027 (USD MILLION)
TABLE 114 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2021 (KT)
TABLE 115 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2022–2027 (KT)
TABLE 116 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2021 (USD MILLION)
TABLE 117 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2022–2027 (USD MILLION)
TABLE 118 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2021 (KT)
TABLE 119 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2022–2027 (KT)
TABLE 120 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2021 (USD MILLION)
TABLE 121 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2022–2027 (USD MILLION)
TABLE 122 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2021 (KT)
TABLE 123 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2022–2027 (KT)
TABLE 124 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2021 (USD MILLION)
TABLE 125 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2022–2027 (USD MILLION)
TABLE 126 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2021 (KT)
TABLE 127 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2022–2027 (KT)
12.3.1 SPAIN
12.3.1.1 Increased demand for meat and dairy products
TABLE 128 SPAIN: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2021 (USD MILLION)
TABLE 129 SPAIN: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2022–2027 (USD MILLION)
12.3.2 GERMANY
12.3.2.1 Focus on offering high-quality meat products
TABLE 130 GERMANY: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2021 (USD MILLION)
TABLE 131 GERMANY: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2022–2027 (USD MILLION)
12.3.3 FRANCE
12.3.3.1 Rising instances of disease outbreaks
TABLE 132 FRANCE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2021 (USD MILLION)
TABLE 133 FRANCE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2022–2027 (USD MILLION)
12.3.4 ITALY
12.3.4.1 Need for alternative growth promoters encourage use of probiotics
TABLE 134 ITALY: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2021 (USD MILLION)
TABLE 135 ITALY: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2022–2027 (USD MILLION)
12.3.5 UK
12.3.5.1 Intensive farming results in high use of premium quality nutrients in animal intestinal health products
TABLE 136 UK: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2021 (USD MILLION)
TABLE 137 UK: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2022–2027 (USD MILLION)
12.3.6 REST OF EUROPE
12.3.6.1 Need for alternatives to antibiotic growth promoters encourage demand for phytogenics
TABLE 138 REST OF EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2021 (USD MILLION)
TABLE 139 REST OF EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2022–2027 (USD MILLION)
12.4 ASIA PACIFIC
FIGURE 35 ASIA PACIFIC: REGIONAL SNAPSHOT
TABLE 140 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2021 (USD MILLION)
TABLE 141 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2022–2027 (USD MILLION)
TABLE 142 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2021 (USD MILLION)
TABLE 143 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2022–2027 (USD MILLION)
TABLE 144 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2021 (KT)
TABLE 145 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2022–2027 (KT)
TABLE 146 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2021 (USD MILLION)
TABLE 147 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2022–2027 (USD MILLION)
TABLE 148 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2021 (KT)
TABLE 149 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2022–2027 (KT)
TABLE 150 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2021 (USD MILLION)
TABLE 151 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2022–2027 (USD MILLION)
TABLE 152 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2021 (KT)
TABLE 153 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2022–2027 (KT)
TABLE 154 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2021 (USD MILLION)
TABLE 155 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2022–2027 (USD MILLION)
TABLE 156 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2021 (KT)
TABLE 157 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2022–2027 (KT)
12.4.1 CHINA
12.4.1.1 High consumption of meat
TABLE 158 CHINA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2021 (USD MILLION)
TABLE 159 CHINA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2022–2027 (USD MILLION)
12.4.2 JAPAN
12.4.2.1 Preference for high-quality feed products
TABLE 160 JAPAN: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2021 (USD MILLION)
TABLE 161 JAPAN: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2022–2027 (USD MILLION)
12.4.3 INDIA
12.4.3.1 Growing demand for high-quality poultry products
TABLE 162 INDIA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2021 (USD MILLION)
TABLE 163 INDIA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2022–2027 (USD MILLION)
12.4.4 SOUTH KOREA
12.4.4.1 Increase in consumption of meat products
TABLE 164 SOUTH KOREA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2021 (USD MILLION)
TABLE 165 SOUTH KOREA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2022–2027 (USD MILLION)
12.4.5 AUSTRALIA & NEW ZEALAND
12.4.5.1 High consumption of meat products
TABLE 166 AUSTRALIA & NEW ZEALAND: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2021 (USD MILLION)
TABLE 167 AUSTRALIA & NEW ZEALAND: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2022–2027 (USD MILLION)
12.4.6 REST OF ASIA PACIFIC
12.4.6.1 Commercialization of livestock products
TABLE 168 REST OF ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2021 (USD MILLION)
TABLE 169 REST OF ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2022–2027 (USD MILLION)
12.5 SOUTH AMERICA
TABLE 170 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2021 (USD MILLION)
TABLE 171 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2022–2027 (USD MILLION)
TABLE 172 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2021 (USD MILLION)
TABLE 173 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2022–2027 (USD MILLION)
TABLE 174 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2021 (KT)
TABLE 175 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2022–2027 (KT)
TABLE 176 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2021 (USD MILLION)
TABLE 177 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2022–2027 (USD MILLION)
TABLE 178 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2022–2027 (KT)
TABLE 179 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2021 (USD MILLION)
TABLE 180 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2022–2027 (USD MILLION)
TABLE 181 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2021 (KT)
TABLE 182 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2022–2027 (KT)
TABLE 183 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2021 (USD MILLION)
TABLE 184 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2022–2027 (USD MILLION)
TABLE 185 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2021 (KT)
TABLE 186 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2022–2027 (KT)
12.5.1 BRAZIL
12.5.1.1 High demand for meat products due to high purchasing power of people
TABLE 187 BRAZIL: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2021 (USD MILLION)
TABLE 188 BRAZIL: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2022–2027 (USD MILLION)
12.5.2 ARGENTINA
12.5.2.1 Growth in animal husbandry sector
TABLE 189 ARGENTINA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2021 (USD MILLION)
TABLE 190 ARGENTINA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2022–2027 (USD MILLION)
12.5.3 REST OF SOUTH AMERICA
12.5.3.1 Increased awareness among farmers about importance of feed supplements
TABLE 191 REST OF SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2021 (USD MILLION)
TABLE 192 REST OF SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2022–2027 (USD MILLION)
12.6 REST OF THE WORLD
TABLE 193 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2021 (USD MILLION)
TABLE 194 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2022–2027 (USD MILLION)
TABLE 195 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2021 (USD MILLION)
TABLE 196 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2022–2027 (USD MILLION)
TABLE 197 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2021 (KT)
TABLE 198 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2022–2027 (KT)
TABLE 199 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2021 (USD MILLION)
TABLE 200 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2022–2027 (USD MILLION)
TABLE 201 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2021 (KT)
TABLE 202 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2022–2027 (KT)
TABLE 203 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2021 (USD MILLION)
TABLE 204 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2022–2027 (USD MILLION)
TABLE 205 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2021 (KT)
TABLE 206 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2022–2027 (KT)
TABLE 207 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2021 (USD MILLION)
TABLE 208 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2022–2027 (USD MILLION)
TABLE 209 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2021 (KT)
TABLE 210 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2022–2027 (KT)
12.6.1 MIDDLE EAST
12.6.1.1 High demand for animal-based protein products
TABLE 211 MIDDLE EAST: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2021 (USD MILLION)
TABLE 212 MIDDLE EAST: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2022–2027 (USD MILLION)
12.6.2 AFRICA
12.6.2.1 Improvement in livestock health
TABLE 213 AFRICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2021 (USD MILLION)
TABLE 214 AFRICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2022–2027 (USD MILLION)
13 COMPETITIVE LANDSCAPE (Page No. - 187)
13.1 OVERVIEW
13.2 MARKET EVALUATION FRAMEWORK
FIGURE 36 MARKET EVALUATION FRAMEWORK, 2019–2022
13.3 MARKET SHARE ANALYSIS
TABLE 215 ANIMAL INTESTINAL HEALTH MARKET SHARE ANALYSIS, 2021
13.4 REVENUE ANALYSIS FOR KEY COMPANIES, 2019–2021 (USD BILLION)
FIGURE 37 REVENUE ANALYSIS OF KEY COMPANIES, 2019–2021 (USD BILLION)
13.5 COMPANY EVALUATION QUADRANT
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
FIGURE 38 ANIMAL INTESTINAL HEALTH MARKET: COMPANY EVALUATION QUADRANT FOR KEY PLAYERS, 2021
13.6 STARTUP EVALUATION QUADRANT
13.6.1 PROGRESSIVE COMPANIES
13.6.2 STARTING BLOCKS
13.6.3 RESPONSIVE COMPANIES
13.6.4 DYNAMIC COMPANIES
FIGURE 39 ANIMAL INTESTINAL HEALTH MARKET: COMPANY EVALUATION QUADRANT FOR SMES/STARTUPS, 2021
13.7 PRODUCT FOOTPRINT (KEY PLAYERS)
TABLE 216 COMPANY FOOTPRINT, BY LIVESTOCK
TABLE 217 COMPANY FOOTPRINT, BY ADDITIVE
TABLE 218 COMPANY FOOTPRINT, BY REGION
TABLE 219 OVERALL COMPANY FOOTPRINT
13.7.1 COMPETITIVE BENCHMARKING OF KEY PLAYERS
TABLE 220 ANIMAL INTESTINAL HEALTH MARKET: DETAILED LIST OF KEY PLAYERS
13.7.2 COMPETITIVE BENCHMARKING OF SMES/OTHER PLAYERS
TABLE 221 ANIMAL INTESTINAL HEALTH MARKET: DETAILED LIST OF SMES/OTHER PLAYERS
13.8 PRODUCT LAUNCHES, DEALS, AND OTHER DEVELOPMENTS
13.8.1 NEW PRODUCT LAUNCHES
TABLE 222 ANIMAL INTESTINAL HEALTH MARKET: NEW PRODUCT LAUNCHES, 2019–2021
13.8.2 OTHER DEVELOPMENTS
TABLE 223 ANIMAL INTESTINAL HEALTH MARKET: OTHER DEVELOPMENTS, 2019–2020
13.8.3 DEALS
TABLE 224 ANIMAL INTESTINAL HEALTH MARKET: DEALS, 2020-2021
14 COMPANY PROFILES (Page No. - 202)
(Business Overview, Products Offered, Recent Developments, MnM view, Key strengths/right to win, Strategic choices made, Weakness/competitive threats)*
14.1 KEY PLAYERS
14.1.1 ADM
TABLE 225 ADM: BUSINESS OVERVIEW
FIGURE 40 ADM: COMPANY SNAPSHOT
TABLE 226 ADM: PRODUCTS OFFERED
TABLE 227 ADM: OTHERS, 2021
TABLE 228 ADM: PRODUCT LAUNCHES, 2020
14.1.2 KONINKLIJKE DSM N.V.
TABLE 229 KONINKLIJKE DSM N.V.: BUSINESS OVERVIEW
FIGURE 41 KONINKLIJKE DSM N.V.: COMPANY SNAPSHOT
TABLE 230 KONINKLIJKE DSM N.V.: PRODUCTS OFFERED
TABLE 231 KONINKLIJKE DSM N.V.: DEALS, 2020
14.1.3 DUPONT NUTRITION & BIOSCIENCES (DANISCO ANIMAL NUTRITION)
TABLE 232 DUPONT NUTRITION & BIOSCIENCES: BUSINESS OVERVIEW
FIGURE 42 DUPONT NUTRITION & BIOSCIENCES: COMPANY SNAPSHOT
TABLE 233 DUPONT NUTRITION & BIOSCIENCES: PRODUCTS OFFERED
TABLE 234 DUPONT NUTRITION & BIOSCIENCES: DEALS, 2019–2021
TABLE 235 DUPONT NUTRITION & BIOSCIENCES: PRODUCT LAUNCHES, 2019
TABLE 236 DUPONT NUTRITION & BIOSCIENCES: OTHERS, 2020
14.1.4 CARGILL INCORPORATED
TABLE 237 CARGILL INCORPORATED: BUSINESS OVERVIEW
FIGURE 43 CARGILL INC.: COMPANY SNAPSHOT
TABLE 238 CARGILL INCORPORATED: PRODUCTS OFFERED
TABLE 239 CARGILL INCORPORATED: DEALS, 2020
TABLE 240 CARGILL INCORPORATED: OTHERS, 2022
14.1.5 NOVOZYMES
TABLE 241 NOVOZYMES: BUSINESS OVERVIEW
FIGURE 44 NOVOZYMES: COMPANY SNAPSHOT
TABLE 242 NOVOZYMES: PRODUCTS OFFERED
TABLE 243 NOVOZYMES: DEALS, 2020
14.1.6 KEMIN INDUSTRIES INC.
TABLE 244 KEMIN INDUSTRIES INC.: BUSINESS OVERVIEW
TABLE 245 KEMIN INDUSTRIES INC.: PRODUCTS OFFERED
TABLE 246 KEMIN INDUSTRIES: PRODUCT LAUNCHES, 2020
14.1.7 NUTRECO
TABLE 247 NUTRECO: BUSINESS OVERVIEW
FIGURE 45 NUTRECO: COMPANY SNAPSHOT
TABLE 248 NUTRECO: PRODUCTS OFFERED
TABLE 249 NUTRECO: DEALS 2019-2020
14.1.8 CHR. HANSEN HOLDING A/S
TABLE 250 CHR. HANSEN HOLDING A/S: BUSINESS OVERVIEW
FIGURE 46 CHR. HANSEN HOLDING A/S: COMPANY SNAPSHOT
TABLE 251 CHR. HANSEN HOLDING A/S: PRODUCTS OFFERED
TABLE 252 CHR. HANSEN HOLDING A/S: PRODUCT LAUNCHES, 2019–2021
TABLE 253 CHR. HANSEN HOLDING A/S: DEALS, 2020
14.1.9 BLUESTAR ADISSEO CO. LTD.
TABLE 254 BLUESTAR ADISSEO: BUSINESS OVERVIEW
FIGURE 47 BLUESTAR ADISSEO CO. LTD.: COMPANY SNAPSHOT
TABLE 255 BLUESTAR ADISSEO CO. LTD.: PRODUCTS OFFERED
TABLE 256 BLUESTAR ADISSEO CO. LTD.: DEALS, 2020
14.1.10 ALLTECH
TABLE 257 ALLTECH: BUSINESS OVERVIEW
TABLE 258 ALLTECH: PRODUCTS OFFERED
14.1.11 EVONIK INDUSTRIES
TABLE 259 EVONIK INDUSTRIES: BUSINESS OVERVIEW
FIGURE 48 EVONIK INDUSTRIES: COMPANY SNAPSHOT
TABLE 260 EVONIK INDUSTRIES: PRODUCTS OFFERED
TABLE 261 EVONIK INDUSTRIES: PRODUCT LAUNCHES, 2020
14.1.12 LALLEMAND INC.
TABLE 262 LALLEMAND INC.: BUSINESS OVERVIEW
TABLE 263 LALLEMAND INC.: PRODUCTS OFFERED
TABLE 264 LALLEMAND INC.: OTHER DEVELOPMENTS, 2019-2020
14.1.13 BIORIGIN
TABLE 265 BIORIGIN: BUSINESS OVERVIEW
TABLE 266 BIORIGIN: PRODUCTS OFFERED
TABLE 267 BIORIGIN: DEALS, 2019
14.1.14 LAND O’LAKES
TABLE 268 LAND O’LAKES: BUSINESS OVERVIEW
FIGURE 49 LAND O’LAKES: COMPANY SNAPSHOT
TABLE 269 LAND O’LAKES: PRODUCTS OFFERED
TABLE 270 LAND O’LAKES: OTHERS, 2019
TABLE 271 LAND O’LAKES: DEALS, 2019
14.1.15 LESAFFRE
TABLE 272 LESAFFRE: BUSINESS OVERVIEW
TABLE 273 LESAFFRE: PRODUCTS OFFERED
TABLE 274 LESAFFRE: OTHER DEVELOPMENTS, 2019-2020
TABLE 275 LESAFFRE: PRODUCT LAUNCHES, 2019
14.1.16 CALPIS CO LTD
TABLE 276 CALPIS CO LTD.: BUSINESS OVERVIEW
14.1.17 AB VISTA
14.1.18 PURE CULTURES
14.1.19 DR. ECKEL ANIMAL NUTRITION GMBH & CO. KG
14.1.20 UNIQUE BIOTECH
*Details on Business Overview, Products Offered, Recent Developments, MnM view, Key strengths/right to win, Strategic choices made, Weakness/competitive threats might not be captured in case of unlisted companies.
15 ADJACENT AND RELATED MARKETS (Page No. - 252)
15.1 INTRODUCTION
TABLE 277 ADJACENT MARKETS TO ANIMAL INTESTINAL HEALTH
15.2 LIMITATIONS
15.3 PHYTOGENIC FEED ADDITIVES MARKET
15.3.1 MARKET DEFINITION
15.3.2 MARKET OVERVIEW
TABLE 278 PHYTOGENIC FEED ADDITIVES MARKET, BY SOURCE, 2016–2019 (USD MILLION)
TABLE 279 PHYTOGENIC FEED ADDITIVES MARKET, BY SOURCE, 2020–2025 (USD MILLION)
15.4 PROBIOTICS IN ANIMAL FEED MARKET
15.4.1 MARKET DEFINITION
TABLE 280 PROBIOTICS IN ANIMAL FEED MARKET, BY LIVESTOCK, 2017–2020 (USD MILLION)
TABLE 281 PROBIOTICS IN ANIMAL FEED MARKET, BY LIVESTOCK, 2021–2026 (USD MILLION)
16 APPENDIX (Page No. - 255)
16.1 DISCUSSION GUIDE
16.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3 AVAILABLE CUSTOMIZATION
16.4 RELATED REPORTS
16.5 AUTHOR DETAILS
List Tables Figures
To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy